A detailed history of Janney Montgomery Scott LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 923,285 shares of AQST stock, worth $4.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
923,285
Previous 880,485 4.86%
Holding current value
$4.24 Million
Previous $2.29 Million 100.87%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$2.4 - $5.09 $102,720 - $217,852
42,800 Added 4.86%
923,285 $4.6 Million
Q2 2024

Jul 25, 2024

BUY
$2.31 - $4.5 $1.24 Million - $2.42 Million
538,625 Added 157.56%
880,485 $2.29 Million
Q1 2024

May 01, 2024

BUY
$2.01 - $6.09 $687,138 - $2.08 Million
341,860 New
341,860 $1.46 Million

Others Institutions Holding AQST

About Aquestive Therapeutics, Inc.


  • Ticker AQST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,350,700
  • Market Cap $245M
  • Description
  • Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...
More about AQST
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.